Screen Reader Mode Icon
To better determine the regional best practices around health plan management of atopic dermatitis in pediatric patients Midwest AMCP and Impact Education, LLC are surveying managed care professionals. Our educational partner for this program is the National Eczema Association. While the choice of treatment for atopic dermatitis is largely based on the experience and preference of the treating dermatologist and patient preferences, payers are key stakeholders in impacting treatment selection through formulary placement, step therapy, and site-of-care policies which can affect member access.

All information obtained in this process will be used and reported in aggregate only, without individual attribution. Your responses will be kept anonymous and will help us better meet your future educational needs.

Thank you for your participation.

Question Title

* 1. Email 

Question Title

* 2. Please answer the questions that follow. (Please check one box.)

Do you have knowledge of or influence over formulary and/or medical policy decisions for your organization?

Question Title

* 3. Are you a member of the Midwest AMCP affiliate?

0 of 15 answered
 

T